Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

BNP Paribas: Hong Kong leads development of Asian hedge fund industry

Wednesday, May 23, 2012

From Komfie Manalo, Opalesque Asia – Leading the evolution of Asia’s hedge fund industry are Chinese fund managers who use Hong Kong as their hedge funds base, according to Philippe Ricard, head of asset and fund services at BNP Paribas Securities Services.

Ricard told AsianInvestor.net that the fund industry in Asia is experiencing a dramatic change that is expected to see Asian fund managers expand their capabilities to transcend regional boundaries, incentivize regulators and sign bilateral agreements.

He cited the ability of Chinese managers to allocate their clients portfolios directly into interbank bonds and equities markets in China using the RQFII scheme, which has effectively transformed Hong Kong into a major destination where managers are enable to highlight their domestic expertise track record to the global market place.

Mostapha Tahiri, BNP Paribas Securities Services’ head of asset and fund services in Asia, compared the growth of Hong Kong’s funds industry to the development of cross-border UCITS scheme in France.

On a related note, Asia is becoming an important financial center for global fund of hedge funds. Last month, data provider Eurekahedge revealed its latest survey of 100 FoHFs globally that Asia is emerging as the mos......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its